The well-studied SNP rs1800795/-174 G > C that is located in the promoter region of IL6 has been associated with fatigue and survival among breast cancer patients [8, 10–12], and the effects of this SNP appear to vary according to tumour ER-status [8, 10]. Here, IL6 is linked to neoplasm.